Global
Patient Derived Xenografts Market report scope includes a holistic study of
the current dynamics of the market, industry growth and restraints of the
market. It provides the market forecast to 2025, recent developments in the
market and pipeline analysis of the major players. The report also includes a
review of micro and macro forecasts, new entrant strategies, and market
penetration strategies with a comprehensive value chain analysis.
Global Patient Derived Xenografts Market is expected to reach USD 263.98 Million by 2025, from USD 77.8 Million in 2017 growing at a CAGR of 16.5% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-patient-derived-xenografts-market
Global Patient
Derived Xenografts Market, By Type (Mice Models and Rat Models), By Tumor Type
(Gastrointestinal, Gynecological, Respiratory, Urological, Hematological and
others), By Application (Preclinical Drug Development and Biomarker analysis),
By End Users, By Geography (North America, South America, Europe, Asia-Pacific,
Middle East and Africa) and Forecast to 2025.
Market Definition:
This market
report defines the market trends and forecast the upcoming opportunities and
threats of the patient derived xenograft market in the next 8 years. Patient
derived xenograft (PDX) is a process of implanting patient’s tumor tissues into
experimental mice model. Various types of patient-derived orthotropic xenograft
models are available for cancers like chronic lymphocytic leukemia, pancreatic
cancer, gastric cancer, colorectal cancer, intrahepatic cholangiocarcinoma. PDX
models help in the assessment of human cancer biology, identification of
therapeutic drugs, preclinical screening, and evaluation of drugs. PDX models
are valuable tools for evaluation of chemical entity, monoclonal antibody,
anti-cancer microorganisms and drug combination in-vivo. Chimeric antigen
receptors (CAR) Tcells have receptors (CAR) Tcells have a promising treatment for
B cell leukemia. PDX are frequently used for CART-cell therapy. As per American
Cancer Society, 4000 to 6000 patients are suffering from gastrointestinal
cancer, 234030 from lung cancer (121,680 in men and 112,350 in womenevery year.
In September 2014, Horizon Discovery Group plc acquired Sage Labs Inc., which
is a leader in the generation of advanced in-vivo transgenic disease models.
This acquisition of Sage Labe Inc. Horizon Discovery Group will help in
expanding company’s genetically engineered preclinical models for cancers.
Major
Market Drivers and Restraints:
·
Increased research and
development in pharmaceutical and biotechnology company
·
Government support in
pharmaceutical and biotechnology industry
·
Increased in the number of
cancer patients
·
Inflation in demand of
personalized medicines
·
Advancement in technology for
developing better applications.
·
Downward pricing pressure owing
to its commodity nature
Market
Segmentation:
The global patient
derived xenografts market is segmented on basis of type, tumor type,
application, end users and geography.
Based on type, the global patient derived
xenografts market is segmented into mice models and rat models.
Based on the tumor type, the global patient
derived xenografts market is segmented into hematological tumor models,
urological tumor models, respiratory tumor models, gynecological tumor models,
gastrointestinal tumor models and other tumor models.
Based on the application, global patient
derived xenograft market is segmented into discovery and preclinical drug
development and basic cancer research and biomarker analysis.
On the basis of end users, the global
patient derived xenografts market is segmented into hospitals and surgical
centers, oncology centers, clinics, community healthcare, others.
Based on geography, the global patient
derived xenografts market report covers
data points for 28 countries across multiple geographies namely North America
& South America, Europe, Asia-Pacific and, Middle East & Africa. Some
of the major countries covered in this report are U.S., Canada, Germany,
France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South
Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil
among others.
Order
a copy of Global Patient Derived Xenografts Market Report @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-patient-derived-xenografts-market
This report consists of below pages:
·
No of pages: 350
·
No of Figures: 60
·
No of Tables: 220
Competitive Analysis:
The global patient derived
xenograft market is highly fragmented and the major players have used various
strategies such as new product launches, expansions, agreements, joint
ventures, partnerships, acquisitions, and others to increase their footprints
in this market. The report includes market shares of patient derived xenograft
market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors/Players:
Some of the major players
operating in the global patient
derived xenografts market are Bioduro, Champion Oncology, Inc, Charles
River, Crown Bioscience Inc, EPO Berlin-Buch GmbH, Hera BioLabs, Horizon
Discovery Group plc, Oncodesign, Pharmatest Services, Shanghai LIDE, The
Jackson Laboratory, Urolead, WuXi AppTec, Xenopat, xentech, among others.
Research Methodology:
Data collection and base year
analysis is done using data collection modules with large sample sizes. The
market data is analyzed and forecasted using market statistical and coherent
models. Also market share analysis and key trend analysis are the major success
factors in the market report. To know more please Request an Analyst Call or
can drop down your inquiry.
Demand Side Primary Contributors:
Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group
Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare
Authorities, Universities, Technological Writers, Scientists, Promoters, Investors
among others.
Supply Side Primary Contributors:
Product Managers, Marketing Managers, C-Level Executives, Distributors, Market
Intelligence, Regulatory Affairs Managers among others
View
Full Report Visit @ http://databridgemarketresearch.com/reports/global-patient-derived-xenografts-market/
Related
Report
Global
Wearable Devices Market – Trends and Forecast to 2024
Global Wearable
Devices Market, By Product Type (Wristwear, Eyewear, Footwear, Neckwear,
Bodywear, Others), By Industry (Consumer Products, Healthcare, Industrial, and
Others), By Type (Smart Textile (Passive, Active, Ultra Smart) (Sensing, Energy
Harvesting, Luminiscence, Thermo Electricity), Non-Textile), By Technology, By
Component, By Geography (North America, Europe, Asia-Pacific, South America,
Rest of the World) – Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Data Bridge adepts in creating satisfied clients
who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our
glorious 99.9 % client satisfying rate.
Contact:
Vishal
Dixit
Data
Bridge Market Research
Tel:
+1-888-387-2818